Everdrone awarded a patent to enable drone operations in complex airspace

Everdrone awarded a patent to enable drone operations in complex airspace

GOTHENBURG, SWEDEN – Oct. 5, 2020: Everdrone, a global leader in autonomous drone technology, announces today that it has been approved for its first patent by the European Patent Office (EPO). Everdrone’s latest patented technology focuses on combining vision technology with unmanned aerial vehicles (UAV) to allow drones to fly safely and accurately in low altitude airspace where obstacles such as buildings and vegetation are often present.

More specifically, the recently approved patent relates to a method of comparing camera data in order to automatically validate that the onboard sensors are working correctly, thereby making drone operations safer.“We’re thrilled about the approval of Everdrone’s first patent,” says Mats Sällström, CEO of Everdrone. “This patent demonstrates our commitment to safety and strengthens our position as a leader and innovator in the industry. This is one of several patents we’re working towards to continue driving our primary mission of saving lives.”

Everdrone offers a service where drones equipped with Automated External Defibrillators (AEDs) and other medical supplies are dispatched to the scene of emergency situations, in conjunction with local emergency services and authorities. The company works with Sweden’s national emergency call centre, SOS Alarm, and the Centre for Resuscitation Science at Karolinska Institutet (KI) for research and development.

Most recently, Everdrone expanded its reach into Denmark in partnership with Copenhagen Emergency Medical Services. Copenhagen EMS acts as a research partner and is responsible for emergency dispatch services to determine which calls need priority drone assistance, while Everdrone coordinates the delivery of AEDs via drone to the scene of cardiac arrests.

For more information about Everdrone, visit www.everdrone.com.

ABOUT EVERDRONE

Everdrone AB develops technology for autonomous drones. The company’s test and development facilities are located at Säve Airport near Gothenburg. The company focuses on civil applications for commercial drones, primarily for use within the healthcare and emergency response sector. Everdrone also actively works with regulatory issues associated with drones specializing in urban operations.

To date, the company has performed more than 13,000 autonomous flights in laboratory and outdoor settings, as well as more than 1.8 million simulated flights. For more information, visit www.everdrone.com

Press